Clinical Trials List
Protocol NumberMK-1026-008
Active
2022-12-01 - 2031-12-31
Phase III
Recruiting3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Huai-Hsuan Huang Division of Hematology & Oncology
- - - Division of General Internal Medicine
- CHENG-HONG TSAI Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Chien-Chin Lin Division of Others -
- Wen-Chien Chou Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 顏志傑 未分科
- Ya-Ping Chen 未分科
- Ya-Ting Hsu 未分科
- Chun-Hui Lee 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
300 participants
